BNTX BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit 6 days ago BioNTech posts wider-than-expected Q4 loss of $0.33/share as COVID vaccine revenue plunges 24% year-over-year; founders to exit for new mRNA… BioNTech SE (BNTX) Reports Q4 Earnings 1 week ago **BioNTech SE Reports Q4 2025 Results**